Liora ter Horst

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial

Alexander P. J. Vlaar, Sanne de Bruin, Matthias H. Busch et al. · The Lancet Rheumatology · 2020 · 198 citations · Full text

Clinical Infectious Disease, Covid-19 Pandemic, Immunology +7

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Alexander P. J. Vlaar, Martin Witzenrath, Pieter van Paassen et al. · The Lancet Respiratory Medicine · 2022 · 131 citations · Full text

Critical Care Medicine, Clinical Infectious Disease, Anti-c5a Antibody +6

Pneumococcal Meningitis in Adults: A Prospective Nationwide Cohort Study Over a 20-year Period

Diederik L H Koelman, Matthijs C. Brouwer, Liora ter Horst et al. · Clinical Infectious Diseases · 2021 · 66 citations · Full text

Community-acquired Bacterial Meningitis in Adults With Cerebrospinal Fluid Leakage

Liora ter Horst, Matthijs C. Brouwer, Arie van der Ende et al. · Clinical Infectious Diseases · 2019 · 60 citations · Full text

Diagnostic accuracy of inflammatory markers in adults with suspected central nervous system infections

Sabine E. Olie, Steven L. Staal, Liora ter Horst et al. · Journal of Infection · 2024 · 20 citations · Full text